Donate

#insulin4all USA

New $55 Insulin Pens Mark Step in California’s Fight Against Insulin Price Gouging

New $55 Insulin Pens Mark Step in California’s Fight Against Insulin Price Gouging

The state of California will take significant steps forward to increase insulin access and affordability – beginning January 1, 2026, CalRx will offer a box of five insulin pens for $55 to anyone who needs it. California announced that Civica will contract with India-based biosimilar manufacturer Biocon to fulfill its commitment to bring low-cost insulin glargine (a long-acting and not name-brand insulin) to California through the CalRx label. Read more

Fixing a Broken System: The Path to Public Pharma in New York

Fixing a Broken System: The Path to Public Pharma in New York

On Thursday, September 25, 2025, T1International brought policy leaders, advocates, and patients together at NYU Law for “Fixing a Broken System: The Path to Public Pharma in New York,” a major public event highlighting the urgent need for publicly controlled pharmaceutical production to counter skyrocketing drug prices. Read more

Our Strategic Plan: Building a movement for Accessible, Affordable, and Equitable Diabetes Care

Our Strategic Plan: Building a movement for Accessible, Affordable, and Equitable Diabetes Care

At T1International, over a decade of grassroots organizing, storytelling, advocacy, and action have brought us to this critical moment. Our community has grown to include people with diabetes, caregivers, and allies from over 150 countries, all united by a shared vision: a world where everyone has the access to the insulin, supplies, and care they need to survive and truly live. Read more

Global Diabetes Advocates Urge Novo Nordisk’s New CEO to Prioritize People Over Profits
T1International statement regarding largest cuts to healthcare coverage in American History.

T1International statement regarding largest cuts to healthcare coverage in American History.

The recently passed “One Big Beautiful Bill” represents the largest and greatest healthcare loss in American history, cutting health care for 17 million people living in this country. This bill, passed in the United States Congress today, is a profound and deadly cut for people living with diabetes, their families, and marginalized and disabled people across the country.
Read more

"I Wasn’t a ‘Bad Diabetic.’ I Just Couldn’t Afford Insulin."
Findings from T1International's 2024 Out-of-Pocket Expenses and Rationing Survey
T1International’s Impact in 2024

T1International’s Impact in 2024

Read more

U.S. Action 2025: Circus of Pharma Greed!
T1International Year in Review: 2024

T1International Year in Review: 2024

As 2024 comes to an end, we’re taking a moment to reflect on the collective power of the T1International community. This year has been filled with challenges and victories as we’ve worked together to fight for affordable and accessible insulin. Here’s a month-by-month look at what we’ve accomplished, thanks to your support and the dedication of advocates across the globe. Read more